Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Greater Metropolitan Mumbai: Trends over Time

Abstract

BackgroundWhile the high burden of multidrug-resistant tuberculosis (MDR-TB) itself is a matter of great concern, the emergence and rise of advanced forms of drug-resistance such as extensively drug-resistant TB (XDR-TB) and extremely drug-resistant TB (XXDR-TB) is more troubling. The aim of this study was to investigate the trends over time of patterns of drug resistance in a sample of MDR-TB patients in greater metropolitan Mumbai, India.MethodsThis was a retrospective, observational study of drug susceptibility testing (DST) results among MDR-TB patients from eight health care facilities in greater Mumbai between 2005 and 2013. We classified resistance patterns into four categories: MDR-TB, pre-XDR-TB, XDR-TB and XXDR-TB.ResultsA total of 340 MDR-TB patients were included in the study. Pre-XDR-TB was the most common form of drug-resistant TB observed overall in this Mumbai population at 56.8% compared to 29.4% for MDR-TB. The proportion of patients with MDR-TB was 39.4% in the period 2005–2007 and 27.8% in 2011–2013, while the proportion of those with XDR-TB and XXDR-TB was changed from 6.1% and 0% respectively to 10.6% and 5.6% during the same time period. During the same periods, the proportions of patients with ofloxacin, moxifloxacin and ethionamide resistance significantly increased from 57.6% to 75.3%, from 60.0% to 69.5% and from 24.2% to 52.5% respectively (p<0.05).DiscussionThe observed trends in TB drug-resistance patterns in Mumbai highlight the need for individualized drug regimens, designed on the basis of DST results involving first- and second-line anti-TB drugs and treatment history of the patient. A drug-resistant TB case-finding strategy based on molecular techniques that identify only rifampicin resistance will lead to initiation of suboptimal treatment regimens for a significant number of patients, which may in turn contribute to amplification of resistance and transmission of strains with increasingly advanced resistance within the community.

The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia

“…The incidence of second line injectable drugs resistance was 3.4%. Several other studies have found much higher rate of FQs resistance in MDR-TB patients, reported as 10%, 13%, 24%, 35% and 57% [41][42][43][44][45]. The increase in FQ resistance might be due to extensive prescription of FQs for treatment of respiratory and other bacterial infections and easy accessibility in some areas even available in local drug markets without prescription.…”

Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study

“…19, 20 Recognizing this, the Revised National TB Control Program (RNTCP) has formulated an ambitious National Strategic Plan (NSP, 2012–2017), with the goal of “universal access to quality TB diagnosis and treatment for all TB patients in the community”. 21 This is consistent with the End TB Strategy by WHO, which emphasizes patient-centered care, and engagement of all providers.…”

A Retrospective Analysis of Multi-Drug Resistant Tuberculosis among Presumptive Pulmonary Drug-Resistant Tuberculosis Patients in Andaman & Nicobar Islands

“…This is also true of the conclusions derived from other similar studies. [12][13][14] The Union Territory of Andaman and Nicobar is a group of islands in the Bay of Bengal more than 1000 kilometres away from mainland India. It is divided into three administrative districts-North and Middle Andaman, South Andaman and Nicobar, each having a district tuberculosis centre.…”